Related Experiment Videos
Familial thrombophilia: a complex genetic disorder
B P Koeleman1, P H Reitsma, R M Bertina
1Haemostasis and Thrombosis Research Centre, University Hospital Leiden, The Netherlands.
Seminars in Hematology
|July 1, 1997
Summary
Familial thrombophilia is now viewed as a complex genetic disorder, not a simple dominant trait. Research focuses on identifying multiple gene defects contributing to thrombosis risk.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Familial thrombosis was historically considered an autosomal dominant trait with reduced penetrance.
- Recent understanding reframes familial thrombophilia as a complex genetic disorder involving multiple gene defects.
Purpose of the Study:
- To review known genetic defects in familial thrombophilia.
- To explore the relationship between gene mutations, plasma abnormalities, and thrombosis.
- To discuss strategies for identifying novel genetic risk factors.
Main Methods:
- Literature review of genetic defects (Protein C, Protein S, Antithrombin deficiencies, Factor V Leiden).
- Analysis of genotype-phenotype correlations in thrombosis.
- Discussion of genetic approaches for risk factor identification.
Main Results:
- Known genetic defects include deficiencies in Protein C, Protein S, and Antithrombin, and Factor V Leiden mutation.
- These defects show varying associations with plasma abnormalities and thrombosis risk within families and the general population.
- Evidence supports familial thrombosis as an oligogenetic disorder.
Conclusions:
- Familial thrombophilia is a multifactorial condition influenced by several genetic factors.
- Identifying new genetic risk factors is crucial for a comprehensive understanding and management of thrombosis.
- Genetic approaches are essential for unraveling the complex etiology of familial thrombophilia.